Excess intravascular coagulation complicating low cardiac output.

In 42 children with congenital heart disease coagulation factor levels were studied serially during the first 20 hours following cardiopulmonary bypass surgery. The acyanotic patients, and also cyanotic patients who survived the operation, showed a progressive improvement in their coagulation profile from initial low postoperative levels. In 12 cyanotic patients who died within 72 hours, however, the coagulation factor levels either remained low, or fell further, until death. Fresh frozen plasma was administered to eight of these patients without apparent benefit. The abnormal coagulation profile correlated significantly with low skin temperature and increased blood loss and was considered to represent excess intravascular coagulation secondary to low cardiac output and poor tissue perfusion.

[1]  H. Ekert,et al.  Preoperative and postoperative platelet function in cyanotic congenital heart disease. , 1974, The Journal of thoracic and cardiovascular surgery.

[2]  J. Lewis,et al.  Improvement in hemostasis following phlebotomy in cyanotic patients with heart disease. , 1973, The Journal of pediatrics.

[3]  J. Stuart,et al.  Consumption coagulopathy in congenital heart-disease. , 1973, Lancet.

[4]  A. Castañeda,et al.  Serial coagulation studies in patients undergoing Mustard procedure. , 1973, The Annals of thoracic surgery.

[5]  R. Engelman,et al.  Disseminated intravascular coagulation following extracorporeal circulation. , 1972, The Journal of thoracic and cardiovascular surgery.

[6]  H. Maurer,et al.  Impairment in platelet aggregation in congenital heart disease. , 1972, Blood.

[7]  H. Bahnson,et al.  An outbreak of hemorrhage following cardiopulmonary bypass. Epidemiologic studies. , 1972, The Journal of thoracic and cardiovascular surgery.

[8]  H. Gralnick,et al.  The hemostatic response to open-heart operations. , 1971, The Journal of thoracic and cardiovascular surgery.

[9]  D. Komp,et al.  Polycythemia in cyanotic heart disease--a study of altered coagulation. , 1970, The Journal of pediatrics.

[10]  D. Sabiston,et al.  Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass. , 1968, The Journal of thoracic and cardiovascular surgery.

[11]  N. Thurnherr Blood Coagulation Studies and Extracorporeal Circulation in Man , 1967, Thrombosis and Haemostasis.

[12]  D. Woodfield,et al.  Fibrin degradation products in sera of normal subjects. , 1967, British medical journal.

[13]  A. Allan,et al.  Effect of mental stress on the fibrinolytic reactivity to exercise. , 1967, British medical journal.

[14]  M. Conrad,et al.  Heparin treatment of haemorrhagic diathesis in cyanotic congenital heart-disease. , 1967, Lancet.

[15]  C. Merskey,et al.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. , 1966, Blood.

[16]  A. S. Douglas,et al.  The haemostatic defect following extracorporeal circulation , 1966, The British journal of surgery.

[17]  R. Biggs,et al.  Treatment of haemophilia and other coagulation disorders , 1966 .

[18]  D. Jackson HEMORRHAGIC DIATHESIS IN PATIENTS WITH CYANOTIC CONGENITAL HEART DISEASE: PREOPERATIVE MANAGEMENT * , 1964, Annals of the New York Academy of Sciences.

[19]  B. C. Ellis,et al.  A quick and accurate method for the determination of fibronogen in plasma. , 1961, The Journal of laboratory and clinical medicine.

[20]  A. Fletcher,et al.  The mechanism of clot dissolution by plasmin. , 1959, The Journal of clinical investigation.

[21]  R. Hartmann A hemorrhagic disorder occurring in patients with cyanotic congenital heart disease. , 1952, Bulletin of the Johns Hopkins Hospital.

[22]  P. Cohen,et al.  Partial purification and properties of a proteolytic enzyme of human serum. , 1949, The Journal of biological chemistry.